FDA Eyes Label Changes for Celiac Safety

US regulators are initiating efforts to enhance food labeling for consumers with celiac disease or those adhering to a gluten-free diet. The Food and Drug Administration has launched a Request for Information to gather public input on the disclosure of grains such as rye and barley, and potential cross-contamination issues with oats.

Currently, major allergens must be listed, but rye and barley are not mandated unless a product is specifically labeled gluten-free. This prompts individuals with celiac disease to scrutinize ingredient lists for these less commonly disclosed grains. The FDA's action is a preliminary measure to inform future policies and potential regulatory actions.

Celiac disease impacts about one in 133 Americans, with increasing prevalence and a significant portion remaining undiagnosed. Gluten ingestion can cause intestinal damage, leading to various symptoms and long-term health issues. The FDA's move is part of a broader interest in rising food allergies. While stricter gluten-free labeling has improved choices, concerns remain about cross-contamination and the presence of gluten in non-food items like medications and cosmetics.